Mucus and H-pylori

被引:0
|
作者
Allen, A [1 ]
Newton, J [1 ]
Oliver, L [1 ]
Jordan, N [1 ]
Strugala, V [1 ]
Pearson, JP [1 ]
Dettmar, PW [1 ]
机构
[1] RECKITT & COLMAN PROD LTD,KINGSTON HULL,N HUMBERSIDE,ENGLAND
来源
关键词
mucus; pepsin; bicarbonate; peptic ulceration;
D O I
暂无
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
A continuous, adherent mucus gel layer with mucosal bicarbonate secretion is the initial protective barrier in the stomach and duodenum against erosion by the gastric juice. H. pylori resides within the adherent mucus gel layer close to the epithelial surface. The barrier function of the mucus layer in vivo depends on (i) its thickness, and (ii) its gel structure, a property which is linearly dependent on the polymeric mucin content. We have shown in vivo that H, pylori colonisation alone did not decrease the thickness of the adherent gastric mucus barrier, although there was a mean 20% decrease in mucus thickness in those H. pylori positive subjects with underlying gastric atrophy. There was, however, a significant mean 18% reduction in the gel-forming polymeric mucin content of mucus from H. pylori subjects, independent of underlying atrophy. Studies in vivo suggest this loss of gel structure might arise from a H. pylori mediated, high local pH generated by urease activity rather than by proteolysis. This study shows that H. pylori infection alone does not compromise the overall integrity of the mucus barrier in vivo. However, in the immediate environment of the organism there appears to be a localised loss of mucus gel structure. The mucus barrier is compromised if H. pylori associated gastric atrophy or peptic ulceration follows.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [1] The amount of H-pylori in gastric mucus during the anti-H-pylori treatment.
    Furuta, T
    Arai, H
    Futami, H
    Takashima, M
    Hanai, H
    Kaneko, E
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A121 - A121
  • [2] Is repeated exposure to H-pylori necessary for chronic H-pylori infection?
    Kugathasan, S
    Czinn, SJ
    [J]. HELICOBACTER, 1997, 2 (03) : 155 - 156
  • [3] Evaluation of the RIBA test to detect H-pylori infection and to discriminate for virulent H-pylori isolates in H-pylori infected patients
    vanderEnde, A
    vanderHulst, RWM
    Roorda, PLH
    Tytgat, GNJ
    Dankert, J
    [J]. GUT, 1997, 41 : A74 - A74
  • [4] H-pylori and diabetes
    Danesh, JN
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (12) : 2576 - 2576
  • [5] H-pylori infection
    Phull, PS
    Jacyna, MR
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 1996, 46 (402): : 48 - 49
  • [6] H-pylori and ageing
    Ito, Kyoko
    Abudayyeh, Suhaib
    Tabassam, Fazal H.
    Graham, David Y.
    El-Zimaity, Hala
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A571 - A571
  • [7] H-pylori strains in household members of children with H-pylori infection.
    Elitsur, Y
    Saeed, D
    Neace, C
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A112 - A112
  • [8] Identification of H-pylori DNA in feces by PCR assay in patients with H-pylori infection
    Li, C
    Ha, T
    Chi, DS
    Jiang, C
    Ferguson, DA
    Thomas, E
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A174 - A174
  • [9] Characterization of H-pylori CagA EPIYA motifs in H-pylori strains of Turkish Origin
    Guvenir, M.
    Yilmaz, O.
    Olivares, A.
    Gonen, C.
    Sarioglu, S.
    Ellidokuz, H.
    Soyturk, M.
    Simsek, I.
    Perez, G. I. Perez
    [J]. HELICOBACTER, 2010, 15 (04) : 370 - 370
  • [10] Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H-pylori eradication
    Slomiany, BL
    Piotrowski, J
    Slomiany, A
    Konturek, JW
    Domschke, WW
    [J]. GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 31 (02): : 227 - 231